WithdrawnNot Applicable

Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program

Stopped: 0 participants

0Started 2020-07-13

Plain-language summary

This study investigates the major complication rate in cancer patients potentially eligible for a hospital at home program for management of neutropenic fever. "Hospital at Home" is a home care program that provides acute, inpatient care in a patient's home in place of a traditional hospital stay. Learning more about the characteristics of potentially eligible patients, including reasons for inpatient admission, rates of major complications, and situations or treatments that would be difficult to deliver in an at home setting may help to inform future program development.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admitted to MD Anderson Cancer Center through the Emergency Center with a diagnosis of neutropenic fever between 1/1/2019 and 12/31/2019 * Be at low risk for major complications as defined by a Multinational Association for Supportive Care in Cancer (MASCC) score \< 21 Exclusion Criteria: * Reside in a nursing home * Homelessness * Hospice enrollment * A secondary reason for admission to the hospital or high risk clinical feature not captured in the MASCC score that places them at high risk for major complications in a hospital at home program

What they're measuring

Percentage of patients who experience major complications that require escalated care

Timeframe: 1 month

Trial details

NCT IDNCT04557709

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-18

View on ClinicalTrials.gov More Hematopoietic and Lymphoid Cell Neoplasm trials